MXPA05006326A - Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad. - Google Patents

Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad.

Info

Publication number
MXPA05006326A
MXPA05006326A MXPA05006326A MXPA05006326A MXPA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A
Authority
MX
Mexico
Prior art keywords
diabetes
medicines
guanidine
substituted derivatives
variously substituted
Prior art date
Application number
MXPA05006326A
Other languages
English (en)
Spanish (es)
Inventor
Corelli Federico
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of MXPA05006326A publication Critical patent/MXPA05006326A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
MXPA05006326A 2002-12-17 2003-12-01 Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad. MXPA05006326A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000625A ITRM20020625A1 (it) 2002-12-17 2002-12-17 Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
PCT/IT2003/000792 WO2004054967A1 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity

Publications (1)

Publication Number Publication Date
MXPA05006326A true MXPA05006326A (es) 2005-08-26

Family

ID=32587901

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006326A MXPA05006326A (es) 2002-12-17 2003-12-01 Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad.

Country Status (12)

Country Link
US (1) US7368605B2 (enExample)
EP (1) EP1575912A1 (enExample)
JP (1) JP2006509816A (enExample)
KR (1) KR20050089058A (enExample)
CN (1) CN1729172A (enExample)
AU (1) AU2003288534B2 (enExample)
BR (1) BR0317397A (enExample)
CA (1) CA2506685A1 (enExample)
IT (1) ITRM20020625A1 (enExample)
MX (1) MXPA05006326A (enExample)
PL (1) PL378416A1 (enExample)
WO (1) WO2004054967A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873368B1 (fr) * 2004-07-26 2008-01-04 Merck Sante Soc Par Actions Si Derives de guanidine et leurs utilisations en therapeutique
CN101062906B (zh) * 2006-04-26 2012-02-08 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐水合物及其用于戒毒,抗炎,降血糖以及胍丁胺代谢异常所致疾病的用途
CN101121677B (zh) * 2006-08-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐二水合物及其医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
IT1219846B (it) * 1988-02-24 1990-05-24 Consiglio Nazionale Ricerche Nuovi derivati guandinici ad attivita' ipotensia,composizione che li contengono e relativo procedimento di estrazione e purificazione da materiale botanico
EP0600973A1 (en) * 1991-08-27 1994-06-15 The Upjohn Company A method for treatment of metabolic disorders and metabolism
GB9511757D0 (en) * 1995-05-19 1995-08-02 Univ Strathclyde Agents for reducing weight
PL327471A1 (en) * 1995-12-22 1998-12-07 Smithkline Beecham Plc Aminoguanidines for trweating niddm

Also Published As

Publication number Publication date
JP2006509816A (ja) 2006-03-23
KR20050089058A (ko) 2005-09-07
CA2506685A1 (en) 2004-07-01
AU2003288534A1 (en) 2004-07-09
EP1575912A1 (en) 2005-09-21
AU2003288534B2 (en) 2009-07-02
US20060069100A1 (en) 2006-03-30
PL378416A1 (pl) 2006-04-03
WO2004054967A1 (en) 2004-07-01
CN1729172A (zh) 2006-02-01
US7368605B2 (en) 2008-05-06
BR0317397A (pt) 2005-11-16
ITRM20020625A1 (it) 2004-06-18

Similar Documents

Publication Publication Date Title
GT200100183A (es) Derivados de quinolina y quinazolina.
BR0107815A (pt) Derivados aminados de di-hidro-1,3,5-triazina e suas aplicações em terapêutica
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
MY135222A (en) Substituted phenylacetamides and their use as glucokinase activators
ES2171077T3 (es) Composicion para mejorar el metabolismo de la glucosa y de la insulina en animales de compañia.
CY1110753T1 (el) Αναστολεις της 11-βητα-υδροξυστεροειδους αφυδρογονασης i
BR0114310A (pt) Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos
MXPA04006802A (es) Derivados de acido fenil(alquil)carboxilico y derivados fenilalquilheterociclicos dionicos y su uso como medicinas con actividad reductora de glucosa en suero y/o de lipidos en suero..
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
CY1106771T1 (el) Φαρμακευτικη συνθεση η οποια χρησιμοποιειται για τον ελεγχο της γλυκοζης του αιματος σε ασθενεις με διαβητη τυπου 2
KR970704440A (ko) 당뇨병 타입 ⅱ의 치료용 약물에의 케토코나졸 및 관련 물질의 용도(use of ketoconazole and related substances in medicaments for treatment of type ⅱ diabetes)
EP1561472A4 (en) SOLID PREPARATION
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
TW200420531A (en) Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
SE0302129D0 (sv) Farmaceutiska kompositioner med antibiotisk aktivitet
MXPA03002160A (es) Metodo para el tratamiento de resistencia a insulina en obesidad y diabetes.
BR0209650A (pt) Análogos de adenosina para o tratamento da sìndrome de resistência à insulina e da diabetes
ATE266632T1 (de) Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen
IL172898A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
ATE449066T1 (de) Biguanidderivate
BR0208109A (pt) Derivados de guanidina bicìclicos e usos terapêuticos destes
DE602004012984D1 (de) Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii
DE60321175D1 (de) Dichloracetat in kombination mit kardioprotektiven oder hämodynamischen medikamenten
BR0317397A (pt) Derivados de guanidina variadamente substituìdos e seu uso como medicamentos com atividade antidiabetes e/ou antiobesidade
TW200500376A (en) Novel adenosine analogues and their use as pharmaceutical agents

Legal Events

Date Code Title Description
FA Abandonment or withdrawal